IJMCR ISSN: 2321–3124
Articles can be submission online
We Follow Peer Review Process
Call for Papers: July/Aug 2017 Issue
Welcome to IJMCR
 

Article Published In Vol.5 (May-June-2017)

Estimation of Serum Interleukin-6 level as a Useful Marker for Clinical Severity of Sickle Cell Disease among Sudanese Patients

Author : Alaaeddin M.Elzubeir, Anna Alobied, Hala Halim, Mayadah Awad, Somia Elfaki, Maysoon Mohammed, Osman A. Saddig

Download PDF

Background: Sickle cell disease (SCD) is an inherited disease characterized by a complex and varied physiopathology and exhibits wide clinical diversity. SCA’s variability and pose significant management challenges to all medical staff
Objectives: We aimed in this study to correlate between serum interleukin-6 level and the clinical severity events of SCD in Sudanese Patients
Method: Case control study conducted on 133 patients with Sickle cell disease were collected and level of serum Il-6 were determined by ELISA and compared to 93 appearantly healthy individuals as Control group.
Result: There was significant association between elevation in serum IL-6 and development of complications in SCD, Chi squared (χ²) = 0.000 (P < 0.05).
Conclusion: These findings indicated that serum level of IL-6 may contribute to susceptibility to many crisis and may use as useful marker for early broadcasting tool for SCD crisis.

Keywords: Sickle Cell Disease, Severity, Serum IL-6, SCD Marker

Announcements

About IJMCR

All the persons belonging directly or indirectly to Microbiology, Biotechnology, Biochemistry, Virology, Environmental Sciences, Medical and Pharmaceutical Sciences, Food and Nutrition, Botany, Zoology, Mycology, Phycology and Agricultural Sciences.